Rights and permissions
About this article
Cite this article
GSK's R&D for neglected diseases, Russia's first TB, HIV/AIDS programme. Pharmacoecon. Outcomes News 408, 11 (2003). https://doi.org/10.1007/BF03276136
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276136